Their market potential is enormous...
Their market potential is enormous...
You are receiving this email because you are subscribed to Behind the Markets. If you no longer wish to receive these emails, please unsubscribe here. Dear Fellow investor,
Early investors in Amgen earned big gains.
And we believe early investors in this biotech have the potential to do the same.
Their patented CRISPR technology has the potential to edit DNA - "cutting" the harmful genes and "pasting" the healthy ones.
It's been called a "once-in-a-generation" opportunity.
And as a dominant player, this firm controls the CRISPR patent other companies must license.
Their market potential is enormous.
Is this tiny company the next Amgen? |
Our mailing address is:
Behind the Markets, LLC
4260 NW 1st Avenue, Suite 55
Boca Raton, FL 33431
Copyright © 2024 Behind the Markets, LLC, All rights reserved.
You're receiving this email as part of your subscription to Behind the Markets. For more information about our privacy practices, please review our Privacy Policy or our Legal Notices.
Behind the Markets
Unsubscribeinvisiblelink
|
|
Tidak ada komentar:
Posting Komentar